Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Acta Derm Venereol ; 103: adv12314, 2023 Nov 20.
Artigo em Inglês | MEDLINE | ID: mdl-37982727

RESUMO

Despite emerging evidence and advances in the management of atopic dermatitis there a lack of consensus regarding the diagnostic criteria, therapeutic approach, method to assess severity, and patient follow-up for this condition. An expert consensus study was conducted to provide recommendations on the management of patients with moderate-to-severe atopic dermatitis. The study used Delphi-like methodology based on a literature review, a summary of the scientific evidence, and a 2-round survey. The agreement of 60 panellists on 21 statements was evaluated. Consensus was pre-defined as ≥ 80% agreement of all respondents. In the first round 6 statements reached consensus. Unanimous consensus was achieved regarding therapeutic goals and patient satisfaction (maintained in the long term and periodic goals reassessment recommended every 3-6 months). In the second round, half of the statements reached consensus, all related to patient follow-up, treatment goals, and atopic comorbidities. The statements that did not reach consensus were related to diagnosis (biomarkers, allergy, and food testing) and starting patients on conventional systemic treatment rather than advanced treatment. The study assessed expert opinion regarding a variety of topics related to the clinical approach to patients with moderate-to-severe atopic dermatitis, in order to provide guidance on the diagnosis and management of patients with atopic dermatitis.


Assuntos
Dermatite Atópica , Hipersensibilidade , Humanos , Dermatite Atópica/diagnóstico , Dermatite Atópica/terapia , Técnica Delphi , Administração Cutânea , Consenso
2.
Acta Derm Venereol ; 101(2): adv00402, 2021 Feb 17.
Artigo em Inglês | MEDLINE | ID: mdl-33491094

RESUMO

Currently no treat-to-target framework to guide systemic treatment in adults with moderate-to-severe atopic dermatitis exists. We sought to reach international consensus through an eDelphi process on a core set of recommendations for such an approach. Recommendations were developed by an international Steering Committee, spanning 3 areas (Guiding Principles, Decision Making, and Outcome Thresholds) and 2 specific time-points; an initial acceptable target at 3 months and an optimal target at 6 months, each based on improvements in patient global assessment plus at least one specific outcome domain. These treat-to-target- orientated recommendations were evaluated by an extended international panel of physicians, nurses and patients. Proposed recommendations were rated using a 9-point Likert scale; for each recommendation, consensus agreement was reached if ≥ 75% of all respondents rated agreement as ≥ 7. Consensus on 16 core recommendations was reached over 2 eDelphi rounds. These provide a framework for shared decision-making on systemic treatment continuation, modification, or discontinuation.


Assuntos
Dermatite Atópica , Eczema , Adulto , Consenso , Técnica Delphi , Dermatite Atópica/diagnóstico , Dermatite Atópica/tratamento farmacológico , Humanos
3.
Contact Dermatitis ; 84(6): 395-406, 2021 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-33534191

RESUMO

BACKGROUND: Fragrances constitute the second most frequent cause of allergic contact dermatitis in Spain. OBJECTIVES: To determine the rate of sensitization to the individual fragrances of fragrance mix (FM) I and FM II for each of the demographic and clinical factors included in the MOAHLFA (male, occupational dermatitis, atopic dermatitis, hand dermatitis, leg dermatitis, facial dermatitis, age) index. METHODS: We conducted a 5-year retrospective study in 23 Spanish centres. We identified the patients who had undergone patch testing with a specific fragrance series after reacting positively to fragrance markers in a baseline series. We obtained the MOAHLFA index items in this population, then calculated for each demographic and clinical factor the frequencies of sensitization to the individual fragrances of FM I and FM II. RESULTS: A specific fragrance series was patch tested in 1013 patients. The most frequent allergens in men, women, children, and retired people were Evernia prunastri (16%), geraniol (16.6%), isoeugenol (17.9%), and geraniol (22.4%), respectively. Citral (20.5%) and hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) (14.5%) were the most common allergens in occupational eczemas and were also associated with a large proportion of hand and facial dermatitis. CONCLUSIONS: Frequency of sensitization to the individual fragrances of FM I and FM II varies with age, sex, affected body region, and history of occupational or atopic dermatitis.


Assuntos
Dermatite Alérgica de Contato/epidemiologia , Dermatite Alérgica de Contato/etiologia , Odorantes , Adulto , Idade de Início , Criança , Dermatite Atópica/epidemiologia , Dermatite Atópica/etiologia , Dermatite Ocupacional/epidemiologia , Dermatite Ocupacional/etiologia , Dermatoses Faciais/epidemiologia , Dermatoses Faciais/etiologia , Feminino , Dermatoses da Mão/etiologia , Humanos , Dermatoses da Perna/epidemiologia , Dermatoses da Perna/etiologia , Masculino , Testes do Emplastro/métodos , Estudos Retrospectivos , Espanha/epidemiologia
4.
Contact Dermatitis ; 82(4): 211-217, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-31625171

RESUMO

INTRODUCTION: Allergic contact dermatitis (ACD) of the feet accounts for approximately 10% of all patch tested patients. OBJECTIVE: To study the clinical profile of patients with feet dermatitis and relevant contact allergens in Spain over a 10-year period. METHODS: Retrospective observational study of patients with suspected ACD from the GEIDAC (Spanish Research Group on Contact Dermatitis and Cutaneous Allergy) baseline series from eight hospitals in Spain between 2004 and 2014. The clinical data collected from each patient were age, sex, occupation, history of atopic dermatitis, and eczema location. RESULTS: A total of 450 cases clinically presented dermatitis affecting the feet; of these, 41% of were males and 5.6% were suspected to be of occupational origin. As much as 47% were diagnosed with ACD, 20% with atopic dermatitis/dyshidrotic eczema, and 5% with psoriasis. The "feet group" included statistically significantly more females in the age range of 21 to 60 years. The most frequent relevant contact allergens were potassium dichromate, cobalt(II) chloride, p-tert-butylphenol formaldehyde resin, mercapto mix, and mercaptobenzothiazole. CONCLUSIONS: ACD is the most frequent clinical diagnosis of feet dermatitis in our series. The most frequent allergens are similar to those published in other series of foot ACD in Europe and the trend has not changed in the studied decade.


Assuntos
Dermatite Alérgica de Contato/epidemiologia , Dermatoses do Pé/epidemiologia , Adulto , Cobalto/efeitos adversos , Dermatite Alérgica de Contato/etiologia , Dermatite Atópica/epidemiologia , Dermatite Atópica/etiologia , Dermatite Irritante/epidemiologia , Dermatite Irritante/etiologia , Dermatite Ocupacional/epidemiologia , Dermatite Ocupacional/etiologia , Eczema Disidrótico/epidemiologia , Feminino , Dermatoses do Pé/induzido quimicamente , Humanos , Masculino , Dicromato de Potássio/efeitos adversos , Psoríase/induzido quimicamente , Psoríase/epidemiologia , Resinas Sintéticas/efeitos adversos , Estudos Retrospectivos , Espanha/epidemiologia , Compostos de Sulfidrila/efeitos adversos
5.
Contact Dermatitis ; 80(2): 94-100, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30430587

RESUMO

BACKGROUND: Fragrance chemicals constitute the second most frequent cause of contact allergy in Spain. There are no data available concerning the individual fragrances that are most frequently involved. OBJECTIVES: To describe the diagnostic contribution provided by specific fragrance series to the results obtained with baseline series fragrance markers by correlating the results of both series. MATERIALS AND METHODS: We performed a 5-year retrospective study of fragrance marker-positive patients tested with specific fragrance series in 23 Spanish centres. We collected the demographic and clinical characteristics, and compared the results of patch tests obtained from different suppliers. RESULTS: Of 19 588 patients patch tested with the Spanish baseline series, 1590 (8.1%) reacted positively to a fragrance marker. Of these, 1013 (63.7%) were patch tested with a fragrance series, and 664 patients reacted positively to at least one individual fragrance other than hydroxyisohexyl 3-cyclohexene carboxaldehyde. Geraniol was the most frequent allergen. Positive reactions to substances not included in fragrance mix (FM) I or FM II were found in 230 patients. Of the 436 FM I-positive patients and the 419 FM II-positive patients, 184 (42%) and 64 (39.1%), respectively, had no positive reactions to fragrance series. In the case of FM I, negative results were more common when individual fragrances were patch tested at low concentrations. CONCLUSIONS: We recommend patch testing all patients positive for any fragrance marker with a specific fragrance series. The correlation between the results of baseline series and fragrance series could be improved by increasing the concentrations of individual fragrances.


Assuntos
Dermatite Alérgica de Contato/epidemiologia , Dermatite Ocupacional/epidemiologia , Dermatoses Faciais/epidemiologia , Dermatoses da Mão/epidemiologia , Dermatoses da Perna/epidemiologia , Perfumes/efeitos adversos , Monoterpenos Acíclicos , Adulto , Idoso , Idoso de 80 Anos ou mais , Aldeídos/efeitos adversos , Anti-Infecciosos/efeitos adversos , Cumarínicos/efeitos adversos , Cicloexenos/efeitos adversos , Dermatite Alérgica de Contato/etiologia , Dermatite Ocupacional/etiologia , Eugenol/efeitos adversos , Eugenol/análogos & derivados , Dermatoses Faciais/etiologia , Farneseno Álcool/efeitos adversos , Feminino , Dermatoses da Mão/etiologia , Humanos , Dermatoses da Perna/etiologia , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Monoterpenos/efeitos adversos , Myroxylon/efeitos adversos , Testes do Emplastro , Propanóis/efeitos adversos , Estudos Retrospectivos , Espanha/epidemiologia , Terpenos/efeitos adversos
6.
Contact Dermatitis ; 76(2): 74-80, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27896835

RESUMO

BACKGROUND: Limonene and linalool are common fragrance terpenes widely used in cosmetic, household and hygiene products. Their primary oxidation products formed after air exposure, the hydroperoxides, have been recognized as important contact haptens. OBJECTIVES: To investigate the prevalence of contact allergy to hydroperoxides of limonene (Lim-OOHs) and hydroperoxides of linalool (Lin-OOHs) in Spain, and to define the optimal concentration for screening in consecutive patients. METHODS: Three different concentrations of Lim-OOHs (0.1%, 0.2% and 0.3% pet.) and Lin-OOHs (0.25%, 0.5% and 1.0% pet.) were simultaneously tested in 3639 consecutive patients at 22 departments of dermatology in Spain. RESULTS: Lim-OOHs at 0.1%, 0.2% and 0.3% yielded positive patch test reactions in 1.4%, 3.4% and 5.1% of the tested patients, respectively; and Lin-OOHs at 0.25%, 0.5% and 1.0% yielded positive reactions in 1.3%, 2.9% and 4.9% of the tested patients, respectively. Few irritant (1.5-1.9%) and doubtful reactions (0.4-0.5%) to both terpene hydroperoxides were registered at the highest concentrations tested. CONCLUSIONS: Lim-OOHs and Lin-OOHs can be considered as common causes of contact allergy, and their inclusion in an extended baseline patch test series therefore seems to be appropriate. The patch test preparations of Lim-OOHs 0.3% pet. and Lin-OOHs 1.0% pet. are useful tools for screening of contact sensitization.


Assuntos
Cicloexenos/efeitos adversos , Dermatite Alérgica de Contato/etiologia , Peróxido de Hidrogênio/efeitos adversos , Monoterpenos/efeitos adversos , Perfumes/efeitos adversos , Terpenos/efeitos adversos , Monoterpenos Acíclicos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Dermatite Alérgica de Contato/diagnóstico , Dermatite Alérgica de Contato/epidemiologia , Feminino , Humanos , Limoneno , Masculino , Pessoa de Meia-Idade , Oxirredução , Testes do Emplastro , Prevalência , Estudos Prospectivos , Espanha/epidemiologia , Adulto Jovem
7.
Contact Dermatitis ; 73(3): 163-71, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26080686

RESUMO

BACKGROUND: Contact allergy to fragrances is common, and impairs quality of life, particularly in young women. OBJECTIVE: To provide current results on the prevalences of sensitization to fragrance allergens used as markers in the baseline series of most European countries. METHODS: Data of patients consecutively patch tested between 2009 and 2012 in 12 European countries with fragrance allergens contained in the baseline series were collected by the European Surveillance System on Contact Allergies network and descriptively analysed. Four departments used the TRUE Test(®) system. RESULTS: The 'basic markers' were tested on 51 477 [fragrance mix II (FM II)] to 57 123 [Myroxylon pereirae, balsam of Peru] patients, and yielded positive reactions as follows: fragrance mix I 6.9%, Myroxylon pereirae 5.4%, FM II 3.8%, colophonium 2.6%, and hydroxyisohexyl 3-cyclohexene carboxaldehyde 1.7%, with some regional differences. Prevalences with TRUE Test(®) allergens were lower. Additional fragrances were tested on 3643 (trimethylbenzenepropanol) to 14 071 (oil of turpentine) patients, and yielded between 2.6% (Cananga odorata) and 0.7% (trimethylbenzenepropanol) positive reactions. CONCLUSIONS: Contact allergy to fragrances is common throughout Europe, with regional variation probably being explained by patch test technique, and differences in exposure and referral patterns. The current basic markers of fragrance sensitivity in the baseline series should be supplemented with additional fragrance allergens.


Assuntos
Dermatite Alérgica de Contato/epidemiologia , Testes do Emplastro/métodos , Vigilância da População , Adulto , Alérgenos/efeitos adversos , Europa (Continente)/epidemiologia , Feminino , Humanos , Masculino , Perfumes/efeitos adversos , Vaselina , Prevalência , Estudos Retrospectivos
11.
Dermatitis ; 34(4): 315-322, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37001174

RESUMO

Background: Persistent localized dermatitis (PLD) or eczema flare-ups (EF) may occur in atopic dermatitis (AD) patients treated with dupilumab. They may reflect concomitant allergic contact dermatitis (ACD) exposed by the inhibition of the Th2 pathway by dupilumab in some cases. Objective: To evaluate the prevalence and etiology of these events and the impact of dupilumab on patch test outcome. Methods: We performed patch tests on 54 AD patients treated with dupilumab and evaluated the prevalence and final diagnosis of EF and PLD as well as the patch test results. Results: The patch test results were positive in 20/54 (37.0%). 21/54 patients (38.9%) had PLD and 12/54 (22.2%) had EF. Ten of 54 (18.5%) had both conditions and 11/54 (20.4%) had neither PLD nor EF. 64.5% of PLD involved the face. 83.9% patients with PLD and 90.9% patients with EF were diagnosed with inadequately controlled AD. 9.7% patients with PLD and 4.5% patients with EF were finally diagnosed with ACD. Nine of 21 (42.9%) patients patch tested twice were positive either before and/or during dupilumab. Patch tests results changed over time in all of them. Conclusions: Patch testing assisted us to exclude ACD as the cause of PLD/EF in AD patients treated with dupilumab. Most PLD and EF were, however, diagnosed as poorly controlled AD. Dupilumab appeared to impact the patch test outcomes.


Assuntos
Dermatite Alérgica de Contato , Dermatite Atópica , Humanos , Dermatite Atópica/epidemiologia , Testes do Emplastro , Espanha/epidemiologia , Resultado do Tratamento , Dermatite Alérgica de Contato/diagnóstico , Dermatite Alérgica de Contato/epidemiologia , Dermatite Alérgica de Contato/etiologia , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa